Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 16
2003 11
2004 14
2005 11
2006 9
2007 19
2008 7
2009 10
2010 9
2011 11
2012 13
2013 13
2014 14
2015 10
2016 7
2017 13
2018 15
2019 16
2020 20
2021 42
2022 27
2023 23
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Trends, patterns and relationship of antimicrobial use and resistance in bacterial isolates tested between 2015-2020 in a national referral hospital of Zambia.
Shawa M, Paudel A, Chambaro H, Kamboyi H, Nakazwe R, Alutuli L, Zorigt T, Sinyawa T, Samutela M, Chizimu J, Simbotwe M, Hayashida K, Nao N, Kajihara M, Furuta Y, Suzuki Y, Sawa H, Hang'ombe B, Higashi H. Shawa M, et al. Among authors: sawa h. PLoS One. 2024 Apr 16;19(4):e0302053. doi: 10.1371/journal.pone.0302053. eCollection 2024. PLoS One. 2024. PMID: 38625961 Free PMC article.
Neutralizing immunity against coronaviruses in Tanzanian health care workers.
Barabona G, Ngare I, Kamori D, Nkinda L, Kosugi Y, Mawazo A, Ekwabi R, Kinasa G, Chuwa H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K, Sunguya B, Ueno T. Barabona G, et al. Sci Rep. 2024 Mar 6;14(1):5508. doi: 10.1038/s41598-024-55989-4. Sci Rep. 2024. PMID: 38448564 Free PMC article.
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
Handabile C, Ohno M, Sekiya T, Nomura N, Kawakita T, Kawahara M, Endo M, Nishimura T, Okumura M, Toba S, Sasaki M, Orba Y, Chua BY, Rowntree LC, Nguyen THO, Shingai M, Sato A, Sawa H, Ogasawara K, Kedzierska K, Kida H. Handabile C, et al. Among authors: sawa h. Sci Rep. 2024 Feb 20;14(1):4204. doi: 10.1038/s41598-024-54421-1. Sci Rep. 2024. PMID: 38378856 Free PMC article.
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K, Fukuhara T. Tamura T, et al. Nat Commun. 2024 Feb 8;15(1):1176. doi: 10.1038/s41467-024-45274-3. Nat Commun. 2024. PMID: 38332154 Free PMC article.
Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution.
Kosugi Y, Plianchaisuk A, Putri O, Uriu K, Kaku Y, Hinay AA Jr, Chen L, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M, Ito J; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Kosugi Y, et al. Lancet Microbe. 2024 Apr;5(4):e313. doi: 10.1016/S2666-5247(23)00373-7. Epub 2024 Jan 11. Lancet Microbe. 2024. PMID: 38219759 Free article. No abstract available.
313 results